http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-030172-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
filingDate 2000-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa35a025f0aee870b42e627a4db789dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a66b1bad38ee4728684353712d7842ce
publicationDate 2003-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-030172-A1
titleOfInvention POWDER COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF AN H2 HISTAMINE ANTAGONIST AND TABLET THAT UNDERSTANDS IT
abstract A powder composition comprising an effective amount of a histamine H2 antagonist, an acidulant, and an alkaline material that will react with the acidulant in the presence of water to form carbon dioxide such that said composition is substantially free of acidulant that It contains hydroxyl groups and the acidulant is an acidulant that contains substantially non-hydroxyl groups, solid under ambient conditions. Preferably, the acidulant containing non-hydroxyl groups is selected from the group consisting of adipic acid, succinic acid, fumaric acid, succinic anhydride and mixtures thereof. On the other hand, the histamine H2 antagonist is preferably selected from the group consisting of ranitidine, cimetidine, nizatidine, famotidine and pharmaceutically acceptable salts thereof. Tablets comprising the composition in accordance with the above described, together with a lubricant.
priorityDate 1999-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1110

Total number of triples: 50.